Search research articles
Contact Us
Filters
Showing results (241-250 of 294) with videos related to
Page
of 30
Sort By:
International Journal of Oncology
|
October 9, 2002
The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer
Grant C Sellar, Karen P Watt, Li Li, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology
S G Allan, J Cummings, S Evans, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of tauromustine in cancer patients. Phase I studies
P O Gunnarsson, J Vibe-Petersen, J S Macpherson, et al.
Oncology Reports
|
May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors
J M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumours
J M Bartlett, S P Langdon, W N Scott, et al.
Biochemical Pharmacology
|
August 4, 1992
Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drug
J Cummings, M A Graham, B M Hoey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1994
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group
C Sessa, S Aamdal, I Wolff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 11, 2011
Association of galectin-3 expression with melanoma progression and prognosis
Ewan R Brown, Tamasin Doig, Niall Anderson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma
R C Leonard, G E Smart, J R Livingstone, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 294) with videos related to
Sort By:
Page
of 30
International Journal of Oncology
|
October 9, 2002
The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer
Grant C Sellar, Karen P Watt, Li Li, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology
S G Allan, J Cummings, S Evans, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of tauromustine in cancer patients. Phase I studies
P O Gunnarsson, J Vibe-Petersen, J S Macpherson, et al.
Oncology Reports
|
May 21, 2011
Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors
J M Bartlett, G J Rabiasz, W N Scott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 1998
Transforming growth factor-beta isoform expression in human ovarian tumours
J M Bartlett, S P Langdon, W N Scott, et al.
Biochemical Pharmacology
|
August 4, 1992
Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drug
J Cummings, M A Graham, B M Hoey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1994
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group
C Sessa, S Aamdal, I Wolff, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 11, 2011
Association of galectin-3 expression with melanoma progression and prognosis
Ewan R Brown, Tamasin Doig, Niall Anderson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma
R C Leonard, G E Smart, J R Livingstone, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
Page
of 30